8039102|t|Pharmacotherapy for Alzheimer's disease.
8039102|a|Pharmacotherapy that is effective for AD is a major goal of extensive research programs throughout the world. With the approval of tacrine in the United States, an agent is now available that has demonstrated improvement in cognition for some AD patients. Other similar symptomatic therapies are likely to become available in the near future. In the long term, prevention and cure will be based on understanding pathogenesis, such as the genetic defects that can lead to disease in some families.
8039102	20	39	Alzheimer's disease	Disease	MESH:D000544
8039102	79	81	AD	Disease	MESH:D000544
8039102	172	179	tacrine	Chemical	MESH:D013619
8039102	284	286	AD	Disease	MESH:D000544
8039102	287	295	patients	Species	9606
8039102	479	494	genetic defects	Disease	MESH:D030342
8039102	Negative_Correlation	MESH:D013619	MESH:D000544

